|
2023
|
Invention
|
Inhibitors of pseudomonas aeruginosa virulence factor lasß.
The present invention relates to com... |
|
|
Invention
|
A murine cytomegalovirus vaccine vector for administration in a non-mouse subject.
The invention... |
|
2022
|
Invention
|
Lectin-targeting conjugates.
The present invention relates to a conjugate comprising a ligand sp... |
|
|
Invention
|
Inhibitors of alpha-hemolysin of staphylococcus aureus.
The present invention relates to novel i... |
|
|
Invention
|
Citraconic acid and derivatives thereof for use as a medicament.
Citraconic acid (CA) or derivat... |
|
|
Invention
|
Novel darobactin derivatives.
The present invention relates to darobactin derivatives of formula... |
|
2021
|
Invention
|
Decolonization of enterobacteria, such as klebsiella pneumoniae, from the gut using strains of kl... |
|
|
Invention
|
Inhibitors of pseudomonas aeruginosa virulence factor lasb.
The present invention relates to com... |
|
|
Invention
|
Method for prediction of the guide efficiency when targeting a gene of interest.
The present inv... |
|
|
Invention
|
Polymer-cargo-complexes comprising cross-linked copolymers and cargo molecules.
Polymer-cargo-co... |
|
|
Invention
|
Phytosphingosine derivatives as adjuvants in immune stimulation.
Phytosphingosine derivatives su... |
|
|
Invention
|
Method for synchronising data of a database, computer programme, device for processing data, and ... |
|
|
Invention
|
N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment... |
|
|
Invention
|
Rna detection and transcription-dependent editing with reprogrammed tracrrnas.
The present inven... |
|
2020
|
Invention
|
New pqsr inverse agonists.
The present invention relates to a compounds according to general for... |
|
|
Invention
|
Novel pqsr inverse agonists.
The present invention relates to a compound according to general fo... |
|
|
Invention
|
Bivalent leca inhibitors targeting biofilm formation of pseudomonas aeruginosa.
The present inve... |
|
|
Invention
|
New use of cyclic dinucleotides.
In a first aspect, the present invention relates to cyclic dinu... |
|
|
Invention
|
Crystobactamides. 2 and the use thereof for the treatment or prophylaxis of bacterial infections. |
|
2019
|
Invention
|
Labyrinthopeptins as anti-viral agents. The present invention relates to novel labyrinthopeptin d... |
|
|
Invention
|
Medicament for treatment of liver cancer.
The invention provides a pharmaceutical composition co... |
|
|
Invention
|
Pqsr inverse agonists. Burkholderia infection.
|
|
|
Invention
|
Method for determining vaccine efficacy in an individual and means therefore.
In a first aspect,... |
|
2018
|
Invention
|
Gene cluster for the biosynthetic production of tetracycline compounds in a heterologous host.
T... |
|
|
Invention
|
Medicament for liver regeneration and for treatment of liver failure.
The present invention rela... |
|
|
Invention
|
Chlorotonil derivatives. The present invention relates to novel chlorotonil derivatives of formul... |
|
|
Invention
|
Targeted cytotoxic ratjadone derivatives and conjugates thereof. The present invention is directe... |
|
|
Invention
|
Cystobactamides. 2 (I):
|
|
|
Invention
|
Aminoglycoside derivatives and nano-assemblies thereof, including those with quorum sensing inhib... |
|
|
Invention
|
Salmonella and immunogenic composition containing the same as well as its use. Salmonella strain ... |
|
|
Invention
|
Rapid antimicrobial susceptibility testing and phylogenetic identification.
The present inventio... |
|
2016
|
Invention
|
Labyrinthopeptins as anti-viral agents.
The present invention relates to novel labyrinthopeptin ... |
|
|
Invention
|
Novel family of rna-programmable endonucleases and their uses in genome editing and other applica... |
|
|
Invention
|
Pseudomonas aeruginosa lecb. Pseudomonas aeruginosa. |
|
2015
|
Invention
|
Method and measuring device for determination of the growth rate of biofilm. A method for determi... |
|
|
Invention
|
Cystobactamides. The present invention provides a method for the treatment or prophylaxis of bact... |
|
|
Invention
|
Medicament for liver regeneration and for treatment of liver failure. The present invention relat... |
|
|
Invention
|
1,4,7,10-tetrazacyclododecane based agents to target bacteria and its use. The present invention ... |
|
|
Invention
|
Novel macrolide antibiotics.
The present invention relates to a compound according to general fo... |
|
2014
|
Invention
|
Cystobactamides.
The present invention provides cystobactamides of formula (I) and the use there... |
|
|
Invention
|
Pqsr modulators. The present invention relates to compounds according to general formula (I); to ... |
|
|
Invention
|
Extracellular polyhydroxyalkanoates produced by genetically engineered microorganisms.
The prese... |
|
2013
|
Invention
|
Pha-producing genetically engineered microorganisms.
The present invention is directed at geneti... |
|
|
Invention
|
Pseudomonas aeruginosa lectin inhibitors. Pseudomonas aeruginosa lectin LecB. |
|
|
Invention
|
Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations. D... |
|
|
Invention
|
Synthetic pathway enzymes for the production of argyrins. The invention provides the amino acid s... |
|
2012
|
Invention
|
Inhibitor of colonisation of mucosa.
The present invention relates in the first aspect to the us... |
|
|
Invention
|
Haprolid and derivatives thereof as inhibitors of hcv.
The present invention describes new compo... |
|
2011
|
Invention
|
Methods and vectors for cell immortalisation. The present invention relates to a method and to ve... |
